We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Evidence Reinforcing Approval of New Cancer Drugs Raises Questions

News   Sep 19, 2019 | Original story from BMJ

 
Evidence Reinforcing Approval of New Cancer Drugs Raises Questions
 
 
 

RELATED ARTICLES

Limitations of Health Reports From Direct-to-Consumer Genetic Tests Are Identified

News

According to study findings presented at the American Society of Human Genetics (ASHG) 2019 Annual Meeting, health reports from direct-to-consumer (DTC) genetic tests that adopt a limited variant screening approach are producing clinically false-negative results.

READ MORE

AI Could Warn About Drug Interaction Side Effects

News

Researchers have designed an algorithm that analyzes data on drug-drug interactions listed in reports — compiled by the Food and Drug Administration and other organizations — for use in a possible alert system that would let patients know when a drug combination could prompt dangerous side effects.

READ MORE

Collaboration Fuels Hunt for New “Orphan Disease” Treatments

News

The National Institutes of Health has awarded a Michigan State University researcher a $2.1 million, five-year grant to search vast databases of existing drugs in the hope that some could be adapted to treat orphan diseases.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE